Our Partnering Interests

New ideas. New science. This is what we’re looking for in our search to discover the next generation of breakthrough medicines. Our partnering activities encompass: 

  • Focusing on the discovery and development of new and better medicines for patients in our scientific focus areas.

  • Investigating common pathological mechanisms such as fibrosis and immune modulation that contribute to multiple diseases.

  • Exploring new frontiers in science and technology, outside our scientific focus areas, to anticipate future trends that complement our research strategy.

central nervous system diseases graphic
Partnering Interests

Mental Health disorders

The development of new treatment options for Neuropsychiatric diseases is a key priority for Boehringer Ingelheim
Read more
Partnering Interests

Oncology & Cancer Immunology

Our commitment to innovation in oncology research has resulted in the launch of two products for the treatment of non-small cell lung cancer.
Read more
lung diseases graphic
Partnering Interests

Respiratory

Boehringer Ingelheim is a leader in respiratory medicine with a 100-year history of innovation in this area.
Read more

Downloads